CXCR2 and neoplasm: Together, these findings suggest that IL-8/CXCR2-induced metabolic reprogramming promotes CD47 expression by increasing AC-CoA levels, which increases p65 acetylation and subsequent NF-κB pathway activation, thereby supporting tumour immune evasion.